US Stock MarketDetailed Quotes

ARDS Aridis Pharmaceuticals

Watchlist
  • 0.000
  • +0.000+9900.00%
15min DelayClose Dec 20 16:00 ET
4.46KMarket Cap0.00P/E (TTM)

Aridis Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
76.95%-983K
29.26%-4.34M
60.63%-4M
-26.99%-29.13M
-129.47%-8.56M
50.37%-4.27M
7.08%-6.14M
-153.71%-10.17M
-12.01%-22.94M
26.81%-3.73M
Net income from continuing operations
98.99%-83K
252.20%12.14M
12.23%-6.82M
28.02%-30.37M
27.50%-6.39M
60.77%-8.24M
-45.34%-7.98M
-12.70%-7.77M
-88.93%-42.19M
-51.30%-8.81M
Operating gains losses
----
----
----
----
----
----
----
----
-8,122.22%-722K
--0
Depreciation and amortization
-52.80%59K
-51.91%63K
-33.59%87K
11.95%487K
-36.31%100K
32.98%125K
40.86%131K
43.96%131K
29.08%435K
84.71%157K
Other non cash items
-17.86%676K
-75.00%69K
65.30%605K
-94.83%350K
-493.99%-1.12M
-87.26%823K
--276K
1,009.09%366K
--6.78M
--283K
Change In working capital
-168.55%-1.84M
-1,695.17%-16.83M
155.80%1.88M
-112.35%-1.3M
-140.76%-1.67M
-49.25%2.68M
201.34%1.06M
-253.40%-3.36M
1,804.54%10.52M
5,211.69%4.09M
-Change in receivables
-122.00%-295K
2,292.94%1.86M
189.98%1.14M
-865.65%-1M
-224.62%-992K
223.48%1.34M
-123.74%-85K
-2,111.11%-1.27M
120.73%131K
295.58%796K
-Change in prepaid assets
100.74%7K
-161.49%-404K
19.21%180K
19.10%212K
98.84%344K
-189.35%-940K
161.29%657K
504.00%151K
-77.97%178K
63.21%173K
-Change in payables and accrued expense
-160.80%-1.61M
50.64%1.18M
171.66%1.66M
-96.76%259K
-145.61%-852K
-45.27%2.64M
365.99%782K
-243.99%-2.31M
1,053.87%8M
518.54%1.87M
-Change in other current assets
85.71%78K
--0
--0
85.71%104K
1.79%57K
--42K
--0
--5K
21.74%56K
-26.32%56K
-Change in other current liabilities
-150.00%-20K
-216.67%-19K
-240.00%-17K
---30K
---11K
---8K
---6K
---5K
--0
--0
-Change in other working capital
--0
-6,537.54%-19.45M
-1,817.46%-1.08M
-139.13%-841K
-117.79%-213K
-182.06%-398K
-787.88%-293K
-87.40%63K
--2.15M
--1.2M
Cash from discontinued investing activities
Operating cash flow
76.95%-983K
29.26%-4.34M
60.63%-4M
-26.99%-29.13M
-129.47%-8.56M
50.37%-4.27M
7.08%-6.14M
-153.71%-10.17M
-12.01%-22.94M
26.81%-3.73M
Investing cash flow
Cash flow from continuing investing activities
0
216.67%14K
0
84.53%-82K
-213.95%-49K
0
90.32%-12K
93.73%-21K
-44.41%-530K
112.87%43K
Net PPE purchase and sale
--0
216.67%14K
--0
84.53%-82K
-213.95%-49K
--0
90.32%-12K
93.73%-21K
-44.41%-530K
112.87%43K
Cash from discontinued investing activities
Investing cash flow
--0
216.67%14K
--0
84.53%-82K
-213.95%-49K
--0
90.32%-12K
93.73%-21K
-44.41%-530K
112.87%43K
Financing cash flow
Cash flow from continuing financing activities
280.32%999K
2,278.42%3.03M
-94.08%263K
-57.43%14.78M
122.82%11.03M
-102.37%-554K
6.71%-139K
-32.50%4.44M
300.09%34.72M
-37.72%4.95M
Net issuance payments of debt
-63.33%-735K
--3.24M
-129.70%-1.49M
-36.00%3.2M
-127.00%-1.35M
---450K
--0
--5M
599.30%5M
--5M
Net common stock issuance
--1.74M
--1K
--2.06M
-57.57%12.61M
25,832.65%12.61M
--0
--0
--0
273.82%29.72M
-100.62%-49K
Proceeds from stock option exercised by employees
----
--0
--3K
-40.00%3K
----
----
--0
--0
-64.29%5K
--0
Net other financing activities
--0
-49.64%-208K
44.17%-311K
---1.03M
---230K
---104K
---139K
---557K
----
----
Cash from discontinued financing activities
Financing cash flow
280.32%999K
2,278.42%3.03M
-94.08%263K
-57.43%14.78M
122.82%11.03M
-102.37%-554K
6.71%-139K
-32.50%4.44M
300.09%34.72M
-37.72%4.95M
Net cash flow
Beginning cash position
-93.47%519K
-87.22%1.82M
-72.19%5.56M
128.88%19.99M
-83.26%3.13M
94.33%7.95M
29.80%14.24M
128.88%19.99M
-58.21%8.73M
201.37%18.72M
Current changes in cash
100.33%16K
79.32%-1.3M
34.91%-3.74M
-228.19%-14.43M
91.78%2.43M
-132.94%-4.82M
8.58%-6.29M
-356.43%-5.74M
192.51%11.25M
-49.80%1.27M
End cash Position
-82.92%535K
-93.47%519K
-87.22%1.82M
-72.19%5.56M
-72.19%5.56M
-83.26%3.13M
94.33%7.95M
29.80%14.24M
128.88%19.99M
128.88%19.99M
Free cash flow
76.95%-983K
29.39%-4.34M
60.71%-4M
-24.47%-29.21M
-133.48%-8.61M
51.02%-4.27M
8.62%-6.15M
-134.62%-10.19M
-12.58%-23.47M
32.11%-3.69M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 76.95%-983K29.26%-4.34M60.63%-4M-26.99%-29.13M-129.47%-8.56M50.37%-4.27M7.08%-6.14M-153.71%-10.17M-12.01%-22.94M26.81%-3.73M
Net income from continuing operations 98.99%-83K252.20%12.14M12.23%-6.82M28.02%-30.37M27.50%-6.39M60.77%-8.24M-45.34%-7.98M-12.70%-7.77M-88.93%-42.19M-51.30%-8.81M
Operating gains losses ---------------------------------8,122.22%-722K--0
Depreciation and amortization -52.80%59K-51.91%63K-33.59%87K11.95%487K-36.31%100K32.98%125K40.86%131K43.96%131K29.08%435K84.71%157K
Other non cash items -17.86%676K-75.00%69K65.30%605K-94.83%350K-493.99%-1.12M-87.26%823K--276K1,009.09%366K--6.78M--283K
Change In working capital -168.55%-1.84M-1,695.17%-16.83M155.80%1.88M-112.35%-1.3M-140.76%-1.67M-49.25%2.68M201.34%1.06M-253.40%-3.36M1,804.54%10.52M5,211.69%4.09M
-Change in receivables -122.00%-295K2,292.94%1.86M189.98%1.14M-865.65%-1M-224.62%-992K223.48%1.34M-123.74%-85K-2,111.11%-1.27M120.73%131K295.58%796K
-Change in prepaid assets 100.74%7K-161.49%-404K19.21%180K19.10%212K98.84%344K-189.35%-940K161.29%657K504.00%151K-77.97%178K63.21%173K
-Change in payables and accrued expense -160.80%-1.61M50.64%1.18M171.66%1.66M-96.76%259K-145.61%-852K-45.27%2.64M365.99%782K-243.99%-2.31M1,053.87%8M518.54%1.87M
-Change in other current assets 85.71%78K--0--085.71%104K1.79%57K--42K--0--5K21.74%56K-26.32%56K
-Change in other current liabilities -150.00%-20K-216.67%-19K-240.00%-17K---30K---11K---8K---6K---5K--0--0
-Change in other working capital --0-6,537.54%-19.45M-1,817.46%-1.08M-139.13%-841K-117.79%-213K-182.06%-398K-787.88%-293K-87.40%63K--2.15M--1.2M
Cash from discontinued investing activities
Operating cash flow 76.95%-983K29.26%-4.34M60.63%-4M-26.99%-29.13M-129.47%-8.56M50.37%-4.27M7.08%-6.14M-153.71%-10.17M-12.01%-22.94M26.81%-3.73M
Investing cash flow
Cash flow from continuing investing activities 0216.67%14K084.53%-82K-213.95%-49K090.32%-12K93.73%-21K-44.41%-530K112.87%43K
Net PPE purchase and sale --0216.67%14K--084.53%-82K-213.95%-49K--090.32%-12K93.73%-21K-44.41%-530K112.87%43K
Cash from discontinued investing activities
Investing cash flow --0216.67%14K--084.53%-82K-213.95%-49K--090.32%-12K93.73%-21K-44.41%-530K112.87%43K
Financing cash flow
Cash flow from continuing financing activities 280.32%999K2,278.42%3.03M-94.08%263K-57.43%14.78M122.82%11.03M-102.37%-554K6.71%-139K-32.50%4.44M300.09%34.72M-37.72%4.95M
Net issuance payments of debt -63.33%-735K--3.24M-129.70%-1.49M-36.00%3.2M-127.00%-1.35M---450K--0--5M599.30%5M--5M
Net common stock issuance --1.74M--1K--2.06M-57.57%12.61M25,832.65%12.61M--0--0--0273.82%29.72M-100.62%-49K
Proceeds from stock option exercised by employees ------0--3K-40.00%3K----------0--0-64.29%5K--0
Net other financing activities --0-49.64%-208K44.17%-311K---1.03M---230K---104K---139K---557K--------
Cash from discontinued financing activities
Financing cash flow 280.32%999K2,278.42%3.03M-94.08%263K-57.43%14.78M122.82%11.03M-102.37%-554K6.71%-139K-32.50%4.44M300.09%34.72M-37.72%4.95M
Net cash flow
Beginning cash position -93.47%519K-87.22%1.82M-72.19%5.56M128.88%19.99M-83.26%3.13M94.33%7.95M29.80%14.24M128.88%19.99M-58.21%8.73M201.37%18.72M
Current changes in cash 100.33%16K79.32%-1.3M34.91%-3.74M-228.19%-14.43M91.78%2.43M-132.94%-4.82M8.58%-6.29M-356.43%-5.74M192.51%11.25M-49.80%1.27M
End cash Position -82.92%535K-93.47%519K-87.22%1.82M-72.19%5.56M-72.19%5.56M-83.26%3.13M94.33%7.95M29.80%14.24M128.88%19.99M128.88%19.99M
Free cash flow 76.95%-983K29.39%-4.34M60.71%-4M-24.47%-29.21M-133.48%-8.61M51.02%-4.27M8.62%-6.15M-134.62%-10.19M-12.58%-23.47M32.11%-3.69M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Alphabet-C
GOOG
+1.72%

Unlock the Full List

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-0.12%